IKKβ specifically binds to P16 and phosphorylates Ser8 of P16

Biochemical and Biophysical Research Communications

Volumn 393, Issue 3, 2010, Pages 504-508

  Guo, Yi ^a   Yuan, Chunhua ^a   Weghorst, Christopher M ^a,b   Li, Junan ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

CDK4; IKK ; P16; Phosphorylation

Indexed keywords

CYCLIN DEPENDENT KINASE 4; GLUTAMIC ACID; I KAPPA B ALPHA; I KAPPA B KINASE BETA; PROTEIN P16; SERINE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; I KAPPA B KINASE;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE PROGRESSION; CONTROLLED STUDY; IMMUNOPRECIPITATION; IN VIVO STUDY; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SENESCENCE; SIGNAL TRANSDUCTION; CELL CYCLE; DRUG ANTAGONISM; HUMAN; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE;

CELL CYCLE; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P16; HUMANS; I-KAPPA B KINASE; PHOSPHORYLATION; SERINE;

EID: 77949314655     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.02.035     Document Type: Article

References (15)

1. Sherr C.J., and McCormick F. The RB and p53 pathways in cancer. Cancer Cell 2 (2002) 103-112
2. Kim W.Y., and Sharpless N.E. The regulation of INK4/ARF in cancer and aging. Cell 127 (2006) 265-275
3. INK4a and telomerase may co-modulate endothelial progenitor cells senescence. Ageing Res. Rev. 7 (2008) 137-146
4. Ortega S., Malumbres M., and Barbacid M. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta 1602 (2002) 73-87
5. ARF. Int. J. Oncol. 21 (2002) 401-408
6. INK4A correlates with Cdk4 association. J. Biol. Chem. 278 (2003) 6619-6622
7. Byeon I.J., Li J., Ericson K., Selby T.L., Tevelev A., Kim H.J., O'Maille P., and Tsai M.D. Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4. Mol. Cell 1 (1998) 421-431
8. Li J., Joo S., and Tsai M.D. An NF-κB-specific inhibitor, IκBα, binds to and inhibits cyclin-dependent kinase 4. Biochemistry 42 (2003) 13476-13483
9. Guo Y., Mahajan A., Yuan C., Joo S., Weghorst C.M., Tsai M.D., and Li J. Comparisons of the conformational stability of cyclin-dependent kinase (CDK) 4-interacting ankyrin repeat (AR) proteins. Biochemistry 48 (2009) 4050-4062
10. Higashitsuji H., Higashitsuji H., Liu Y., Masuda T., Fujita T., Abdel-Aziz H.I., Kongkham S., Dawson S., Mayer R.J., Itoh Y., Sakurai T., Itoh K., and Fujita J. The oncoprotein gankyrin interacts with RelA and suppresses NF-κB activity. Biochem. Biophy. Res. Commun. 363 (2007) 879-884
11. Pratt M.A.C., Tibbo E., Robertson S.J., Jansson D., Hurst K., Perez-Iratxeta C., Lau R., and Niu M.Y. The canonical NF-kappaB pathway is required for formation of luminal mammary neoplasias and is activated in the mammary progenitor population. Oncogene 28 (2009) 2710-2722
12. INK4d between the native and partially folded state. ACS Chem. Biol. 4 (2009) 53-63
13. Tevelev A., Byeon I.J., Selby T., Ericson K., Kim H.J., Kraynov V., and Tsai M.D. Tumor suppressor p16INK4A: structural characterization of wild-type and mutant proteins by NMR and circular dichroism. Biochemistry 35 (1996) 9475-9487
14. Jacobs M.D., and Harrison S.C. Structure of an IκBα/NF-κB complex. Cell 95 (1998) 749-758
15. Baeuerle P.A. IκB-NF-κB structures: at the interface of inflammation control. Cell 95 (1998) 729-731